Transcatheter tricuspid valve interventions, particularly edge-to-edge repair, provide a valuable treatment alternative for high-risk patients with tricuspid regurgitation.
This review highlights the rapidly expanding armamentarium of transcatheter devices for treating tricuspid regurgitation in high-risk patients.
Absolute Event Rate: 0% vs 0%
Abstract Tricuspid regurgitation is a frequent and undertreated condition associated with poor outcomes. Over the past decade, transcatheter tricuspid valve interventions have emerged as a valuable alternative for high-risk patients. Edge-to-edge repair is the most widely adopted approach, while replacement technologies are advancing rapidly and offer the potential for near-complete elimination of regurgitation. In parallel, annuloplasty, spacers, and caval devices are broadening the therapeutic spectrum across diverse anatomies. This review outlines the expanding device armamentarium and the key opportunities and challenges in this evolving field.
Estevez-Loureiro et al. (Fri,) reported a other. Transcatheter tricuspid valve interventions, particularly edge-to-edge repair, provide a valuable treatment alternative for high-risk patients with tricuspid regurgitation.